Aker BioMarine ASA (AKBM) Earnings Call Transcripts
About Aker BioMarine ASA
Aker BioMarine ASA (AKBM) is a publicly listed company in the Food Products industry, within the Consumer Staples sector. It trades on OB and is based in NO. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 20 calls on record spanning October 30, 2020 to July 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 20 Aker BioMarine ASA earnings call transcripts on record, spanning October 30, 2020 to July 10, 2026. Based on this history, Aker BioMarine ASA reports quarterly. The most recent call on file is dated July 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AKBM
- Exchange
- OB
- Country
- NO
- Sector
- Consumer Staples
- Industry
- Food Products
- Calls on record
- 20
- First call
- October 30, 2020
- Most recent
- July 10, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Jul 10, 2026 | Read transcript → |
| Q1 FY2026 | Apr 30, 2026 | Read transcript → |
| Q4 FY2025 | Feb 12, 2026 | Read transcript → |
| Q2 FY2025 | Jul 11, 2025 | Read transcript → |
| Q1 FY2025 | Apr 30, 2025 | Read transcript → |
| Q4 FY2024 | Feb 12, 2025 | Read transcript → |
| Q3 FY2024 | Nov 1, 2024 | Read transcript → |
| Q2 FY2024 | Jul 12, 2024 | Read transcript → |
| Q1 FY2024 | Apr 26, 2024 | Read transcript → |
| Q4 FY2023 | Feb 14, 2024 | Read transcript → |
| Q3 FY2023 | Nov 1, 2023 | Read transcript → |
| Q2 FY2023 | Jul 14, 2023 | Read transcript → |
| Q1 FY2023 | Apr 28, 2023 | Read transcript → |
| Q3 FY2022 | Nov 1, 2022 | Read transcript → |
| Q2 FY2022 | Jul 14, 2022 | Read transcript → |
| Q4 FY2021 | Feb 17, 2022 | Read transcript → |
| Analyst/Investor Day | Dec 1, 2021 | Read transcript → |
| Q2 FY2021 | Jul 14, 2021 | Read transcript → |
| Q1 FY2021 | Apr 29, 2021 | Read transcript → |
| Q3 FY2020 | Oct 30, 2020 | Read transcript → |